Shares of Tourmaline Oil Corp. TOU advanced 4.51% to C$66.79 Monday, in what proved to be an otherwise all-around negative trading session for the Canadian market, with the S&P/TSX Composite Index ...

Pacibekitug is under clinical development by Tourmaline Bio and currently in Phase II for Graves' Ophthalmopathy.

Tourmaline Oil Corp. closed C$5.34 short of its 52-week high of C$69.25, which the company reached on May 23rd.

Tourmaline is Canada’s largest natural gas producer and fourth largest midstream operator with an expansive production base ...

周四，BMO Capital Markets对市值约6.2亿美元的生物技术公司Tourmaline Bio (NASDAQ:TRML)启动了覆盖，给予"优于大市"评级，目标价为50.00美元。该股目前交易价格为24.03美元，已吸引了分析师的强烈兴趣，共识目标价在每股49美元至74美元之间。根据 InvestingPro 分析，该公司的整体财务健康评分为2.55（满分5分），属于"良好"水平。

Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report)’s share price was down 3.9% during mid-day trading on Tuesday . The company traded as low as $20.02 and last traded at $20.46. Approximately 15,772 ...

We've seen more insider selling than insider buying at Tourmaline Oil recently. In that time, insider William Kirker dumped CA$4.4m worth of shares. Meanwhile insiders bought CA$1.1m worth. Since the ...

Tourmaline Oil remains fairly valued despite recent underperformance and steady oil and gas prices; investors should wait for a more attractive entry point. TRMLF boasts strong business momentum ...

Detailed price information for Tourmaline Oil Corp (TOU-T) from The Globe and Mail including charting and trades.

The forward-looking information is based on certain key expectations and assumptions made by Tourmaline, including expectations and assumptions concerning the following: prevailing and future ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Leerink Partnrs increased their FY2025 EPS estimates for shares of Tourmaline Bio in a note issued to investors on Wednesday, ...